Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:BJDX NASDAQ:HSDT NASDAQ:LFWD NASDAQ:PAVM On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBJDXBluejay Diagnostics$1.53-0.6%$1.49$1.26▼$12.45$2.30M0.48140,105 shs59,958 shsHSDTHelius Medical Technologies$22.33+22.2%$7.44$5.37▼$1,200.00$19.68M0.741.04 million shs1.99 million shsLFWDLifeward$0.56-0.5%$0.67$0.50▼$4.00$8.83M0.16263,165 shs119,166 shsPAVMPAVmed$0.40+0.4%$0.50$0.30▼$1.77$8.78M1.09272,596 shs117,271 shs The Best Nuclear Energy Stocks to BuyNuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBJDXBluejay Diagnostics-1.91%+8.45%+13.24%-5.52%-79.64%HSDTHelius Medical Technologies+141.67%+210.71%+202.99%+18.02%-97.07%LFWDLifeward-3.90%+4.46%-11.13%-48.89%-83.22%PAVMPAVmed-4.76%-6.95%-11.05%-34.58%-77.52%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBJDXBluejay Diagnostics$1.53-0.6%$1.49$1.26▼$12.45$2.30M0.48140,105 shs59,958 shsHSDTHelius Medical Technologies$22.33+22.2%$7.44$5.37▼$1,200.00$19.68M0.741.04 million shs1.99 million shsLFWDLifeward$0.56-0.5%$0.67$0.50▼$4.00$8.83M0.16263,165 shs119,166 shsPAVMPAVmed$0.40+0.4%$0.50$0.30▼$1.77$8.78M1.09272,596 shs117,271 shs The Best Nuclear Energy Stocks to BuyNuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBJDXBluejay Diagnostics-1.91%+8.45%+13.24%-5.52%-79.64%HSDTHelius Medical Technologies+141.67%+210.71%+202.99%+18.02%-97.07%LFWDLifeward-3.90%+4.46%-11.13%-48.89%-83.22%PAVMPAVmed-4.76%-6.95%-11.05%-34.58%-77.52%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBJDXBluejay Diagnostics 0.00N/AN/AN/AHSDTHelius Medical Technologies 2.00HoldN/AN/ALFWDLifeward 3.00Buy$9.001,508.58% UpsidePAVMPAVmed 3.00Buy$19.004,627.54% UpsideCurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBJDXBluejay Diagnostics$250K9.12N/AN/A$10.34 per share0.15HSDTHelius Medical Technologies$520K46.38N/AN/A$212.95 per share0.10LFWDLifeward$25.66M0.34N/AN/A$2.14 per share0.26PAVMPAVmed$2.99M2.95N/AN/A($0.92) per share-0.44Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBJDXBluejay Diagnostics-$7.72M-$125.15N/A∞N/AN/A-362.07%-299.10%N/AHSDTHelius Medical Technologies-$11.74M-$1,976.28N/A∞N/A-7,215.25%-699.93%-415.24%11/10/2025 (Estimated)LFWDLifeward-$28.94M-$3.12N/AN/AN/A-121.80%-137.91%-90.28%11/11/2025 (Estimated)PAVMPAVmed$39.79M$1.160.35N/AN/A7,144.80%N/A-20.96%11/12/2025 (Estimated)Latest BJDX, PAVM, LFWD, and HSDT EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/14/2025Q2 2025HSDTHelius Medical Technologies-$128.50-$79.73+$48.77-$79.73$0.11 million$0.04 million8/14/2025Q2 2025LFWDLifeward-$0.25-$0.58-$0.33-$0.58$6.62 million$5.72 million8/7/2025Q2 2025BJDXBluejay DiagnosticsN/A-$1.41N/A-$1.41N/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBJDXBluejay DiagnosticsN/AN/AN/AN/AN/AHSDTHelius Medical TechnologiesN/AN/AN/AN/AN/ALFWDLifewardN/AN/AN/AN/AN/APAVMPAVmedN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBJDXBluejay DiagnosticsN/A4.564.56HSDTHelius Medical TechnologiesN/A4.323.69LFWDLifewardN/A2.001.26PAVMPAVmedN/A0.520.52Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBJDXBluejay Diagnostics18.47%HSDTHelius Medical Technologies18.63%LFWDLifeward26.76%PAVMPAVmed19.93%Insider OwnershipCompanyInsider OwnershipBJDXBluejay Diagnostics0.08%HSDTHelius Medical Technologies17.90%LFWDLifeward2.70%PAVMPAVmed7.30%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBJDXBluejay Diagnostics91.49 million1.49 millionNot OptionableHSDTHelius Medical Technologies301.08 million884,000Not OptionableLFWDLifeward6015.70 million15.28 millionOptionablePAVMPAVmed9021.93 million20.33 millionOptionableBJDX, PAVM, LFWD, and HSDT HeadlinesRecent News About These CompaniesLucid Diagnostics Appoints Danielle Scelfo as Senior Vice President, Market Access & Government AffairsSeptember 16 at 8:01 AM | prnewswire.comMedtech company to license Duke’s esophageal precancer detection probeSeptember 15 at 4:25 PM | beckersasc.comBMedtech company to license Duke’s esophageal precancer detection probeSeptember 15 at 4:25 PM | beckersasc.comBLucid Diagnostics Shares Fall After Pricing of Public Stock OfferingSeptember 11, 2025 | marketwatch.comPAVmed’s Lucid Diagnostics Completes Public Stock OfferingSeptember 11, 2025 | tipranks.comLucid Diagnostics Announces Closing of Public Offering of Common StockSeptember 11, 2025 | prnewswire.comLucid Diagnostics Announces Pricing of Public Offering of Common StockSeptember 10, 2025 | prnewswire.comLucid Diagnostics Announces Proposed Public Offering of Common StockSeptember 9, 2025 | prnewswire.comLucid Diagnostics to Host Investor Call on Monday, September 8, 2025September 5, 2025 | prnewswire.comPAVmed enters letter of intent with Duke University to license groundbreaking endoscopic esophageal imaging technologyAugust 28, 2025 | pharmabiz.comPPAVmed plans to license Duke’s oesophageal imaging technologyAugust 28, 2025 | finance.yahoo.comLucid Diagnostics to Participate in the Cantor Global Healthcare Conference 2025August 27, 2025 | prnewswire.comPAVmed to license esophageal imaging technology from Duke TechnologyAugust 26, 2025 | msn.comPavmed licenses endoscopic esophageal imaging tech out of DukeAugust 26, 2025 | massdevice.comPAVmed Signs Letter of Intent to License Groundbreaking Endoscopic Esophageal Imaging TechnologyAugust 26, 2025 | prnewswire.comPAVmed Revenue Jumps 513% in Q2August 14, 2025 | aol.comALucid Diagnostics Reports Q2 2025 Financial ResultsAugust 14, 2025 | msn.comPAVmed Provides Business Update and Reports Second Quarter 2025 Financial ResultsAugust 14, 2025 | prnewswire.comLucid Diagnostics Provides Business Update and Reports Second Quarter 2025 Financial ResultsAugust 13, 2025 | prnewswire.comPAVmed Q2 2025 Earnings PreviewAugust 12, 2025 | msn.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeBJDX, PAVM, LFWD, and HSDT Company DescriptionsBluejay Diagnostics NASDAQ:BJDX$1.53 -0.01 (-0.65%) Closing price 04:00 PM EasternExtended Trading$1.53 0.00 (-0.07%) As of 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Bluejay Diagnostics, Inc., a medical diagnostic company, develops rapid test for the monitoring of disease progression in the United States. It is developing Symphony platform, a technology platform comprising Symphony analyzer that orchestrates blood processing, biomarker isolation, and immunoassay preparation using non-contact centrifugal force; and Symphony Cartridge, which includes reagents and components. The company also offers ALLEREYE diagnostic test, a point-of-care device for the diagnosis of allergic conjunctivitis. In addition, it develops IL-6 for the monitoring of disease progression in critical care; as well as hsTNT/I and NT-proBNP for the monitoring of patients acuity with chest pain. The company was incorporated in 2015 and is headquartered in Acton, Massachusetts.Helius Medical Technologies NASDAQ:HSDT$22.33 +4.06 (+22.22%) Closing price 04:00 PM EasternExtended Trading$22.14 -0.19 (-0.87%) As of 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-implantable technologies for the treatment of symptoms caused by neurological disease or trauma. The company's product is Portable Neuromodulation Stimulator, a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. The company was incorporated in 2014 and is headquartered in Newtown, Pennsylvania.Lifeward NASDAQ:LFWD$0.56 0.00 (-0.48%) Closing price 04:00 PM EasternExtended Trading$0.56 +0.00 (+0.80%) As of 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gravity System for use in physical and neurological rehabilitation and athletic training; MyoCycle devices; and ReBoot, a personal soft exo-suit for home and community use by individuals post-stroke. The company markets and sells its products directly to institutions and individuals, as well as through third-party distributors. The company was formerly known as Argo Medical Technologies Ltd. ReWalk Robotics Ltd. was incorporated in 2001 and is headquartered in Yokneam Illit, Israel.PAVmed NASDAQ:PAVM$0.40 +0.00 (+0.45%) Closing price 03:58 PM EasternExtended Trading$0.41 +0.01 (+1.52%) As of 07:53 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.PAVmed Inc. focuses on acquiring, developing, and commercializing novel products that target unmet needs in the United States. The company's lead products include CarpX, a patented, single-use, disposable, and minimally invasive surgical device for use in the treatment of carpal tunnel syndrome; EsoCheck Esophageal Cell Collection Device, which consists of diagnostic test that serves as a testing tool for preventing esophageal adenocarcinoma deaths, through early detection of esophageal precancer in at-risk gastroesophageal reflux disease, including chronic heartburn and acid reflux or simply reflux in patients; and EsoGuard, a bisulfite-converted next-generation sequencing DNA assay performed on surface esophageal cells collected with EsoCheck. Its product pipeline also comprises EsoCure EsoCure Esophageal Ablation Device for treating dysplastic BE; PortIO, an implantable intraosseous vascular access device; and Veris cancer care platform. The company was formerly known as PAXmed Inc. and changed its name to PAVmed Inc. in April 2015. PAVmed Inc. was incorporated in 2014 and is headquartered in New York, New York. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Resideo Technologies: Institutional Activity Signals 30% Upside Lululemon’s Sell-Off Looks Overdone: A Contrarian Case Palantir’s Commercial Growth Story Is Just Getting Started How Bath & Body Works Is a Perfect Example of a Value Stock The Applied Digital Breakout Is Only the Beginning $100 Million Buyback in Upwork Stock Follows a Strong Quarter Uranium Energy Stock Has Momentum—and More Upside Ahead Why Opendoor Stock Is Soaring—and May Just Be Starting Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
